The U.S. government will pay vaccine maker Moderna $176 million dollars to accelerate development of a vaccine that could be used to prevent bird flu in people. The new funds are for continued development, including a late-stage trial next year if those early study results are positive. Katherine Ward has this story and more in Health Matters for July 3, 2024.
Health Matters
Health Matters: U.S. to pay Moderna $176M to develop bird flu vaccine
More Videos
-
Health Matters: Canadian Food Inspection Agency triggers recall for Baby Gourmet cereal
-
Health Matters: 350k Bissell steam cleaners recalled in Canada over burn hazard
-
Health Matters: E-scooter injuries on the rise, Montreal Children’s Hospital warns
-
Health Matters: Psychotherapy, counselling now tax exempt
-
Health Matters: Unclear if Paris’ Seine River will be ready for Olympic swimmers
-
Health Matters: 5 bird flu cases identified on Colorado poultry farm
You are viewing an Accelerated Mobile Webpage.
View Original Article